KR870010036A - 유기 아연 착화합물의 제조방법 및 활성 성분으로서 그를 함유하는 약학 조성물 - Google Patents
유기 아연 착화합물의 제조방법 및 활성 성분으로서 그를 함유하는 약학 조성물 Download PDFInfo
- Publication number
- KR870010036A KR870010036A KR870003697A KR870003697A KR870010036A KR 870010036 A KR870010036 A KR 870010036A KR 870003697 A KR870003697 A KR 870003697A KR 870003697 A KR870003697 A KR 870003697A KR 870010036 A KR870010036 A KR 870010036A
- Authority
- KR
- South Korea
- Prior art keywords
- hydroxyquinoline
- chloro
- pharmaceutical composition
- formula
- iodo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 10
- 238000004519 manufacturing process Methods 0.000 title claims 5
- 239000004480 active ingredient Substances 0.000 title 1
- 238000000034 method Methods 0.000 claims 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 11
- 229910052725 zinc Inorganic materials 0.000 claims 11
- 239000011701 zinc Substances 0.000 claims 11
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 claims 9
- 230000000843 anti-fungal effect Effects 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 3
- 150000003751 zinc Chemical class 0.000 claims 3
- 239000005725 8-Hydroxyquinoline Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000002270 dispersing agent Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000002538 fungal effect Effects 0.000 claims 2
- 239000002674 ointment Substances 0.000 claims 2
- 229960003540 oxyquinoline Drugs 0.000 claims 2
- 239000006216 vaginal suppository Substances 0.000 claims 2
- 229940120293 vaginal suppository Drugs 0.000 claims 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical group [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- -1 alkali metal salt Chemical class 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
- 239000004246 zinc acetate Substances 0.000 claims 1
- 239000011592 zinc chloride Substances 0.000 claims 1
- 235000005074 zinc chloride Nutrition 0.000 claims 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical group [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims 1
- 229960001763 zinc sulfate Drugs 0.000 claims 1
- 229910000368 zinc sulfate Inorganic materials 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/30—Metal salts; Chelates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU861623A HU196554B (en) | 1986-04-18 | 1986-04-18 | Process for production of medical compounds with fungicidal effect |
| HU1623 | 1986-04-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR870010036A true KR870010036A (ko) | 1987-11-30 |
Family
ID=10955373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR870003697A Ceased KR870010036A (ko) | 1986-04-18 | 1987-04-17 | 유기 아연 착화합물의 제조방법 및 활성 성분으로서 그를 함유하는 약학 조성물 |
Country Status (24)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0355383A1 (de) * | 1988-07-28 | 1990-02-28 | Ciba-Geigy Ag | Solubilisierungsverfahren |
| EP0433457B1 (en) * | 1989-06-12 | 1994-10-19 | Shiseido Company Limited | Antipruritic composition |
| US5219847A (en) * | 1989-06-12 | 1993-06-15 | Shiseido Company, Ltd. | Antipruritic composition |
| US7846919B2 (en) * | 1998-02-10 | 2010-12-07 | Dermex Pharmaceuticals, Llc | Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions |
| AU2011332834B2 (en) * | 2010-11-25 | 2016-02-04 | Zzakey Technologies Ltd. | Biodegradable fire-fighting formulation |
| CN111937886A (zh) * | 2019-05-16 | 2020-11-17 | 兰州大学 | 一种8-羟基喹啉配合物的制备及其在防治植物病害中的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH494760A (de) * | 1962-11-30 | 1970-08-15 | Metalsalts Corp | Verfahren zur Herstellung von Metall-8-chinolinolaten mit Ausnahme der Alkalimetallderivate |
| US3886277A (en) * | 1967-02-14 | 1975-05-27 | Schwarzkopf Gmbh Hans | Methods of controlling dandruff using 5,7-dichloro-8-hydroxy quinoline |
| BE755584A (fr) * | 1969-09-19 | 1971-03-01 | Ugine Kuhlmann | Nouveaux medicaments a activite amoebicide |
| DE2154020A1 (de) * | 1971-10-29 | 1973-05-03 | Hoechst Ag | Metallkomplexe von substituierten benzimidazolen |
| NO156672C (no) * | 1975-10-24 | 1987-11-04 | Chapman Chem Co | Preparat med antimikrobiell og eventuelt insekticid virkning og anvendelse av et slikt preparat som tre- og vekstbeskyttelsesmiddel. |
| ZA786259B (en) * | 1977-11-09 | 1979-10-31 | Procter & Gamble | Therapeutic composition |
| DE3129685C2 (de) * | 1981-07-28 | 1986-11-06 | geb. Stoffel Annemarie Dr. 7802 Merzhausen Buck | Antiseptische Lösung |
-
1986
- 1986-04-18 HU HU861623A patent/HU196554B/hu not_active IP Right Cessation
-
1987
- 1987-03-25 CS CS872035A patent/CS269993B2/cs unknown
- 1987-04-14 CN CN87102747A patent/CN1021632C/zh not_active Expired - Fee Related
- 1987-04-15 US US07/038,656 patent/US4868172A/en not_active Expired - Fee Related
- 1987-04-15 DK DK200087A patent/DK200087A/da not_active Application Discontinuation
- 1987-04-15 ES ES8701110A patent/ES2005165A6/es not_active Expired
- 1987-04-15 CH CH1467/87A patent/CH671880A5/de not_active IP Right Cessation
- 1987-04-16 SE SE8701592A patent/SE8701592L/xx not_active Application Discontinuation
- 1987-04-16 GR GR870617A patent/GR870617B/el unknown
- 1987-04-16 YU YU69387A patent/YU46313B/sh unknown
- 1987-04-16 AU AU71758/87A patent/AU601725B2/en not_active Ceased
- 1987-04-16 NL NL8700906A patent/NL8700906A/nl not_active Application Discontinuation
- 1987-04-16 CA CA000535026A patent/CA1306685C/en not_active Expired - Lifetime
- 1987-04-16 GB GB8709166A patent/GB2189144B/en not_active Expired - Lifetime
- 1987-04-16 FI FI871703A patent/FI871703A7/fi not_active Application Discontinuation
- 1987-04-17 FR FR878705504A patent/FR2597343B1/fr not_active Expired - Lifetime
- 1987-04-17 JP JP62093422A patent/JPS62294616A/ja active Granted
- 1987-04-17 IT IT8720168A patent/IT1207583B/it active
- 1987-04-17 IL IL82238A patent/IL82238A0/xx not_active IP Right Cessation
- 1987-04-17 BG BG079397A patent/BG47945A3/xx unknown
- 1987-04-17 PL PL1987265249A patent/PL265249A1/xx unknown
- 1987-04-17 BE BE8700426A patent/BE1001251A4/fr not_active IP Right Cessation
- 1987-04-17 KR KR870003697A patent/KR870010036A/ko not_active Ceased
- 1987-04-21 DE DE19873713372 patent/DE3713372A1/de active Granted
-
1988
- 1988-08-12 US US07/232,162 patent/US4871728A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4153689A (en) | Stable insulin preparation for nasal administration | |
| KR880006193A (ko) | 피페리딘 화합물 및 그의 제조 및 용도 | |
| KR890002060A (ko) | 옥사졸리디논 화합물 | |
| TNSN90021A1 (fr) | Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales | |
| KR890011838A (ko) | 16-데하이드로 비타민d₃-유도체 | |
| KR890009845A (ko) | 아릴옥시페닐 프로필아민, 이의 제조방법 및 용도 | |
| KR870010036A (ko) | 유기 아연 착화합물의 제조방법 및 활성 성분으로서 그를 함유하는 약학 조성물 | |
| KR900014406A (ko) | 세펨 화합물 및 이의 제조방법 | |
| KR910000647A (ko) | 나프틸아미노-및 나프틸옥시- 피리딘아민 및 관련된 화합물, 이의 제조방법 및 이의 피부소염제로서의 용도 | |
| KR900700098A (ko) | 발기부전의 치료겸 진단용 플라복세이트 및 그 유도체 | |
| KR920004387A (ko) | 진통제 및 피부질환 치료용 국소용 소염제로서의 4-치환된 디하이드로피리도[4,3-d]피리미딘 | |
| KR890008136A (ko) | 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체 | |
| KR900701278A (ko) | 바이러스 감염 치료용 담즙산 | |
| US4742065A (en) | Salts of basic caffeine-8-ethers and their use as pharmaceuticals | |
| KR890003755A (ko) | 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물 | |
| KR910019974A (ko) | 치환된 인돌 | |
| KR880009950A (ko) | 항진균성 2-아닐리노티아졸린 | |
| DE2759108A1 (de) | Verwendung von alpha -mercapto-beta- aryl-acrylsaeuren bei der steigerung des zinkgehaltes im serum und im gewebe | |
| DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
| KR900018013A (ko) | 시아노아세트아미드 유도체, 그의 제조방법 및 그를 유효 성분으로서 함유하는 식물 병해 방제제 | |
| KR900016156A (ko) | 퀴녹살린 유도체 및 궤양치료제 | |
| KR910002450A (ko) | 당뇨병 치료용 제약 조성물 | |
| KR870001153A (ko) | 디페녹시에틸아민 유도체가 함유된 약제조성물 및 그의 생산방법 | |
| DE69328357T2 (de) | Komplex von 2-aminoäthansulfonsäure und zink | |
| KR880006198A (ko) | 2,6-디아미노-3- 할로벤질피리딘, 이의 제조방법 및 이의 약제학적 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19870417 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19920201 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19870417 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19950428 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19950808 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19950428 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |